Related Experiment Video

Updated: May 30, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in

Carolina Herrera1, Martin Cranage, Ian McGowan

  • 1Division of Clinical Sciences, Centre for Infection & Immunity, St George's University of London, UK.

AIDS (London, England)
|August 4, 2011
PubMed
Abstract

Insights

Combinations of reverse transcriptase inhibitors (RTIs) show promise as rectal microbicides. Double and triple RTI combinations were effective against HIV-1 in preclinical colorectal explant models, even against resistant strains.

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Receptive anal intercourse carries the highest risk for HIV transmission.
  • Developing effective rectal microbicides is crucial for HIV prevention strategies.

Purpose of the Study:

  • To evaluate the efficacy of various combinations of reverse transcriptase inhibitors (RTIs) as potential rectal microbicides.
  • To assess the limitations of RTI combinations in preclinical ex-vivo models.

Main Methods:

  • Tested nucleoside, nucleotide, and non-nucleoside RTIs in double, triple, and quadruple combinations.
  • Evaluated antiviral activity using indicator cells and colorectal tissue explants against diverse HIV-1 isolates and RTI-escape variants.

Main Results:

  • All tested RTI combinations demonstrated inhibitory activity against HIV-1 in both cellular and colorectal explant models.
  • Double and triple RTI combinations showed incremental efficacy, including against RTI-escape mutants.
  • Quadruple RTI combinations offered minimal additional benefit over triple combinations.

Conclusions:

  • The colorectal explant model is a valuable tool for preclinical evaluation of microbicide candidates and their combinations.
  • Combinations of RTIs with distinct HIV-1 inhibitory mechanisms hold potential as effective colorectal microbicides.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...